Newsroom | 12270 results

LOS ANGELES--(BUSINESS WIRE)--Fifty Countries Strong: AHF ‘Keeping the Promise’ on World AIDS Day...

DUBLIN--(BUSINESS WIRE)--The "Paracetamol (CAS 103-90-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Paracetamol provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a vital resource for unders...

DUBLIN--(BUSINESS WIRE)--The "Antibody Contract Development & Manufacturing Organization Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering. The global antibody contract development and manufacturing organization (CDMO) market is poised for substantial growth, with its value estimated at USD 21.1 billion in 2024 and projected to soar to USD 45.8 billion by 2033. This represents a CAGR of 9.38% from 2025 to 2033, driven by a surge in demand for monoclonal antibodies...

TAMPA, Fla.--(BUSINESS WIRE)--The following is an opinion editorial provided by Casey Pittock, CEO, Smart Meter: UnitedHealthcare’s decision to sharply limit remote patient monitoring (RPM) reimbursement beginning January 1, 2026, to heart failure and hypertensive disorders of pregnancy, is a disservice to clinicians, patients, and the healthcare system at large. It contradicts federal momentum to modernize chronic care and misrepresents the weight of current evidence on RPM’s clinical value fo...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the BofA Securities Leveraged Finance Conference, being held in Boca Raton, FL, on Tuesday, December 2, 2025, including a fireside chat at 8:10 a.m. ET. The webcast link will be available on the Com...

LEXINGTON, Mass.--(BUSINESS WIRE)--FUJIFILM Healthcare Americas Corporation, a leading provider of enterprise imaging and informatics solutions, will showcase new innovations in its industry leading Synapse medical informatics portfolio at the 2025 Radiological Society of North America (RSNA) Conference & Annual Meeting held November 30 to December 3. The new innovations in booth #3300 include a comprehensive enterprise imaging and informatics solution designed to meet the demands of outpat...

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, will present 10 abstracts across its Precision Oncology portfolio at the 2025 San Antonio Breast Cancer Symposium (SABCS), taking place from December 9-12 in San Antonio, Texas. The data to be presented builds upon Exact Sciences’ long-standing commitment to backing innovation with strong clinical evidence and commitment to equitable breast cancer care. This commitme...

AIX-EN-PROVENCE, France & PARIS & STRASBOURG, France & TOURS, France--(BUSINESS WIRE)--Multidisciplinary group awarded in France 2030 Plan to develop next-generation software-based, smart, and frugal ultrasound imaging devices....

AIX-EN-PROVENCE, France & PARIS & STRASBOURG, France & TOURS, France--(BUSINESS WIRE)--Lauréat du plan France 2030, POCUSI incarne l’ambition française de souveraineté technologique en imagerie médicale. Composé de quatre partenaires nationaux, il vise à développer une nouvelle génération d’échographes logiciels, intelligents et frugaux, capables d’exploiter la puissance de calcul des ordinateurs ou des tablettes. Cette innovation doit répondre aux besoins croissants de dépistage, de surveillan...

ST. LOUIS--(BUSINESS WIRE)--C2N Diagnostics, LLC (“C2N”) announces it has received its laboratory permit from the highly respected New York State Department of Health’s Clinical Laboratory Evaluation Program (CLEP). This accomplishment allows C2N to offer its PrecivityAD2™ and PrecivityAD® blood tests to help diagnose Alzheimer’s disease in New York State. The Empire State joins 49 other states, Washington, D.C., Puerto Rico and select countries across Asia, Latin America, Europe and the Middle...